DocGo Announces Repurchases of Common Stock and Adoption of 10b5-1 Trading Plan for Share Repurchase Program

DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, announced today that as of March 12, 2024, it has repurchased a total of 1.25 million shares of its common stock at an average of $3.88 per share under its share repurchase program announced on January 31, 2024 (the “Repurchase Program”). Pursuant to the Repurchase Program, DocGo is authorized to purchase up to $36 million of its common stock during a 6-month period ending July 30, 2024.

DocGo also announced that it has entered a 10b5-1 trading plan to facilitate repurchases of up to an additional $10 million of its common stock under the Repurchase Program, which will enable the continued purchase of shares during the Company’s quarterly blackout period that begins on March 15, 2024. The 10b5-1 plan will run through May 6, 2024.

“As we continue to deliver exceptional patient care, we remain committed to delivering profitable growth and creating shareholder value,” said Lee Bienstock, CEO of DocGo. “As we previously announced, our full year 2023 results were our strongest to date, and we continue to believe that share repurchases are value enhancing uses of our capital.”

Repurchases under DocGo’s 10b5-1 trading plan will be administered through an independent broker and may be made in the open market at prevailing market prices. All repurchases under the plan will be implemented in accordance with the applicable requirements of Rules 10b5-1 and 10b-18 under the Securities Exchange Act of 1934, as amended.

There can be no assurances as to the actual number or aggregate value of shares that will be repurchased by DocGo pursuant to the Repurchase Program, including the 10b5-1 trading plan.

About DocGo

DocGo is leading the proactive healthcare revolution with an innovative care delivery platform that includes mobile health services, remote patient monitoring and ambulance services. DocGo disrupts the traditional four-wall healthcare system by providing high quality, highly affordable care to patients where and when they need it. DocGo’s proprietary technology and dedicated field staff of certified health professionals elevate the quality of patient care and drive business efficiencies for facilities, hospital networks and health insurance providers. With Mobile Health, DocGo empowers the full promise and potential of telehealth by facilitating healthcare treatment, in tandem with a remote physician, in the comfort of a patient's home or workplace. Together with DocGo's integrated Ambulnz medical transport services, DocGo is bridging the gap between physical and virtual care. For more information, please visit www.docgo.com.